India leads the world with largest number of diabetic subjects earning the dubious distinction of being termed the "diabetes capital of the world." Diabetic peripheral neuropathy developed in the majority of poorly controlled, diabetic patients as a late complication of diabetes. It is therefore of paramount importance to treat diabetic neuropathies appropriately as 50-60% of diabetic populations may progress to suffer from serious life threatening complications. Epalrestat is currently the only Aldose Reductase Inhibitor approved to treat subjective and objective symptoms of Diabetic...
India leads the world with largest number of diabetic subjects earning the dubious distinction of being termed the "diabetes capital of the world." Di...